ClinicalTrialsFinder
RecruitingNot ApplicableNCT07437430

Evaluation of Food Additive Contributions to Obesity: Pilot Study 1

Sponsor

McMaster University

Enrollment

20 participants

Start Date

Feb 10, 2026

Study Type

INTERVENTIONAL

Conditions

Obesity (Disorder)

Summary

The effects of food additives on body weight in humans are largely unknown. This is a pilot cross-over double blind RCT in obese adults aimed to test the feasibility of measuring food consumption over 24 hours after one-time administration of K sorbate versus placebo after participants reduce the background consumption of related food additives.

Eligibility

Min Age: 20 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo one-time administration followed by washout then potassium sorbate one-time administration and Potassium sorbate one-time administration followed by washout then placebo one-time administration for people with obesity (disorder). The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPotassium sorbate one-time administration followed by washout then placebo one-time administration

K sorbate 450 mg will be administered with breakfast during testing session 1, followed by a minimum of 2-week washout and then placebo administration with breakfast during testing session 2

OTHERPlacebo one-time administration followed by washout then potassium sorbate one-time administration

Placebo will be administered with breakfast during testing session 1, followed by a minimum of 2-week washout and then K sorbate 450 mg administration with breakfast during testing session 2

Locations(1)

McMaster University Medical Centre

Hamilton, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07437430

Related Trials

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

NCT072574841 location

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

NCT076534121 location

Dramatherapy for Psychological and Social Well-Being in Obesity and Bariatric Care

NCT076854831 location

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

NCT072270511 location

Targeting Sedentary Behavior Reduction and Physical Fitness Enhancement in Women Before and Beyond Bariatric Surgery- BARIMOV Study Protocol

NCT076639421 location